Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2014 | 06-2014 | 05-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 401 | 0 | N/A | N/A |
| TOTAL | $190 | $555 | $41 | $41 | $41 |
| Non-Current Assets | |||||
| PPE Net | 150 | 163 | 176 | 176 | 176 |
| Other Non-Current Assets | 47 | 47 | 47 | 47 | 47 |
| TOTAL | $197 | $210 | $223 | $223 | $223 |
| Total Assets | $387 | $765 | $264 | $264 | $264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,563 | 1,348 | 396 | 396 | 396 |
| Accounts payable and accrued liabilities | 2,248 | 1,901 | 2,444 | 2,444 | 2,444 |
| Accrued Expenses | 857 | 810 | 626 | 626 | 626 |
| Other current liabilities | N/A | N/A | 4 | 4 | 4 |
| TOTAL | $6,894 | $6,197 | $5,206 | $5,206 | $5,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,145 | 3,056 | 2,855 | 2,855 | 2,855 |
| Other Non-Current Liabilities | 7,624 | 6,805 | 4,904 | 4,904 | 4,904 |
| TOTAL | $10,863 | $9,959 | $7,858 | $7,858 | $7,858 |
| Total Liabilities | $17,756 | $16,155 | $13,064 | $13,064 | $13,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43 | 851 | N/A | 848 | 778 |
| Common Shares | 1 | 28 | 1 | 1 | 1 |
| Retained earnings | -77,211 | -75,190 | -70,637 | -70,637 | -70,637 |
| Other shareholders' equity | -161 | -166 | -166 | -166 | -166 |
| TOTAL | $-17,369 | $-15,391 | $-12,800 | $-12,800 | $-12,800 |
| Total Liabilities And Equity | $387 | $765 | $264 | $264 | $264 |